跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Letrostad - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Letrostad
Approved
STANDARD
Letrostad
Haupt Pharma Münster GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4ef4e2638cceb0ab
Company
Haupt Pharma Münster GmbH
Type
Standard
Approval Details
Approval Id
4ef4e2638cceb0ab
Drug Approval Philippines Name
Letrostad
Product Name
Letrostad
Registration Number
DRP-4394
Brand Name
Letrostad
Generic Name
Letrozole
Dosage Form
Film-Coated Tablet
Dosage Strength
2.5mg
Manufacturer
Haupt Pharma Münster GmbH
Importer
Croma Medic, Inc.
Distributor
Detoxicare Philippines, Inc.
Company Detail Path
/organization/haupt-pharma-munster-gmbh
Issuance Date
12 October 2022
Expiry Date
13 February 2028
Pharmacologic Category
Aromatase Inhibitors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4ef4e2638cceb0ab
Type
Standard
Back to Philippines FDA Approvals